Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Peter S. Hammerman
EZH2 Inhibition Sensitizes BRG1 and EGFR Mutant Lung Tumours to TopoII Inhibitors
Nature
Multidisciplinary
Exome and Genome Sequencing of Nasopharynx Cancer Identifies NF-κB Pathway Activating Mutations
Nature Communications
Astronomy
Genetics
Molecular Biology
Biochemistry
Chemistry
Physics
Development of Covalent Inhibitors That Can Overcome Resistance to First-Generation FGFR Kinase Inhibitors
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Kinase Domain Activation of FGFR2 Yields High-Grade Lung Adenocarcinoma Sensitive to a Pan-FGFR Inhibitor in a Mouse Model of NSCLC
Cancer Research
Cancer Research
Oncology
Immune Profiling of Malignant Pleural Mesothelioma by Flow Cytometry Identifies Distinct T-Cell Activation and Exhaustion Phenotypes in PD-L1 Positive Versus PD-L1 Negative Tumors
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
SHP2 Inhibition Overcomes RTK-mediated Pathway Re-Activation in KRAS Mutant Tumors Treated With MEK Inhibitors
Molecular Cancer Therapeutics
Cancer Research
Oncology
Lymphocyte Transformation by Pim-2 Is Dependent on Nuclear Factor-κB Activation
Cancer Research
Cancer Research
Oncology
